品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A105545-5g | 5g | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
≥95% |
|
|
阿拉丁 | A105545-25g | 25g | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
≥95% |
|
|
阿拉丁 | A105545-1g | 1g | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
≥95% |
|
|
阿拉丁 | A105545-100g | 100g | 期货,请咨询 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
≥95% |
|
|
阿拉丁 | A105545-250mg | 250mg | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
≥95% |
|
|
阿拉丁 | A755468-100tabs | 100tabs | 期货,请咨询 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
tablet |
|
|
阿拉丁 | A755468-50tabs | 50tabs | 期货,请咨询 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
tablet |
|
|
阿拉丁 | A755468-5tabs | 5tabs | 期货,请咨询 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
tablet |
|
|
梯希爱 | A1508-5G | 5G | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑 3-Amino-9-ethylcarbazole |
90.0% |
|
|
梯希爱 | A2167-1G | 1G | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑[用于生化研究] 3-Amino-9-ethylcarbazole[for... |
90.0% |
|
|
梯希爱 | A2167-5G | 5G | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑[用于生化研究] 3-Amino-9-ethylcarbazole[for... |
90.0% |
|
|
阿法埃莎 | B22529-25g | 25g | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑, 95% 3-Amino-9-ethylcarbazole, 95... |
95% |
|
|
阿法埃莎 | B22529-100g | 100g | 现货 | 132-32-1 |
3-氨基-9-乙基咔唑, 95% 3-Amino-9-ethylcarbazole, 95... |
95% |
|
|
阿法埃莎 | C14787-5GR | 5GR | 现货 | 132-32-1 |
3-氨基-9-乙基卡唑 3-Amino-9-ethylcarbazole, 90... |
90% |
|
|
阿法埃莎 | C14787-25GR | 25GR | 现货 | 132-32-1 |
3-氨基-9-乙基卡唑 3-Amino-9-ethylcarbazole, 90... |
90% |
|
|
阿法埃莎 | C14787-100GR | 100GR | 现货 | 132-32-1 |
3-氨基-9-乙基卡唑 3-Amino-9-ethylcarbazole, 90... |
90% |
|
|
毕得 | BD632160-25g | 25g | 现货 | 132-32-1 |
9-乙基-9H-咔唑-3-胺 9-Ethyl-9H-carbazol-3-amine |
95% |
|
|
毕得 | BD632160-1g | 1g | 现货 | 132-32-1 |
9-乙基-9H-咔唑-3-胺 9-Ethyl-9H-carbazol-3-amine |
95% |
|
|
毕得 | BD632160-5g | 5g | 现货 | 132-32-1 |
9-乙基-9H-咔唑-3-胺 9-Ethyl-9H-carbazol-3-amine |
95% |
|
|
毕得 | BD632160-100g | 100g | 现货 | 132-32-1 |
9-乙基-9H-咔唑-3-胺 9-Ethyl-9H-carbazol-3-amine |
95% |
|
|